Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Robert Williams Jr Sells 2,250,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 2,250,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the sale, the insider directly owned 12,315,892 shares of the company’s stock, valued at $141,632,758. The trade was a 15.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Performance

Shares of NASDAQ:AVAH traded up $0.54 during trading on Monday, reaching $13.70. The stock had a trading volume of 5,371,630 shares, compared to its average volume of 1,804,159. Aveanna Healthcare Holdings Inc. has a 52 week low of $5.93 and a 52 week high of $13.98. The firm has a market capitalization of $2.99 billion, a price-to-earnings ratio of 11.14, a P/E/G ratio of 0.92 and a beta of 1.90. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a fifty day simple moving average of $9.58 and a two-hundred day simple moving average of $7.92.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. As a group, analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Royal Bank Of Canada boosted their price objective on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday. Barclays increased their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $10.00 to $11.00 in a report on Friday, May 15th. UBS Group upped their price objective on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday, August 14th. Finally, Wall Street Zen cut shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.89.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its stake in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare during the 2nd quarter worth about $43,000. Summit Securities Group LLC bought a new position in shares of Aveanna Healthcare during the 1st quarter worth about $53,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at about $64,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at about $69,000. 87.96% of the stock is owned by institutional investors.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
• Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
• Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.